ProfileGDS4459 / ENSG00000186113
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 7% 3% 8% 2% 7% 10% 9% 9% 11% 10% 10% 6% 6% 37% 9% 10% 18% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.677
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.363
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.138
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.362
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.247
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.6210
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.279
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.219
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.3611
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.4410
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.6410
GSM623475group B, liver allograft wedge biopsie placebo treatment 21.96
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.076
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.0237
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.219
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.8910
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.2818